93 related articles for article (PubMed ID: 2230341)
1. Rheumatoid factor among several cases of visceral leishmaniasis.
Salama MM
J Egypt Soc Parasitol; 1990 Dec; 20(2):837-9. PubMed ID: 2230341
[TBL] [Abstract][Full Text] [Related]
2. On the specificity of the indirect haemagglutination in diagnosis of visceral leishmaniasis.
Morsy TA; Ahmed MM; Younis TA; Arafa MM
J Egypt Soc Parasitol; 1990 Jun; 20(1):231-4. PubMed ID: 2332651
[TBL] [Abstract][Full Text] [Related]
3. [Application of monoclonal antibodies against Leishmania donovani, II. Detection of circulating antigen in sera of visceral leishmaniasis before and after treatment].
Qu JQ; Xu YX; Bao YF; Yang YT; Wang JY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):21-3. PubMed ID: 2065447
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome as presenting manifestation of visceral leishmaniasis.
Fasanaro AM; Scoleri G; Pizza V; Gaeta GB; Fasanaro A
Lancet; 1991 Nov; 338(8775):1142. PubMed ID: 1682557
[No Abstract] [Full Text] [Related]
5. [Serologic examination of the population of cleaned-up foci of visceral leishmaniasis in the territory of the Uzbek SSR].
Nizamov BB; Tursunov SS; Razakov ShA; Gracheva LI; Saf'ianova VM
Med Parazitol (Mosk); 1989; (6):28-31. PubMed ID: 2534148
[TBL] [Abstract][Full Text] [Related]
6. [Visceral leishmaniasis in Cameroon. Seroepidemiologic survey in the Kousseri region, north Cameroon].
Dondji B; Dereure J; Poste B; Same-Ekobo A; Dedet JP
Bull Soc Pathol Exot; 2001 Dec; 94(5):418-20. PubMed ID: 11889946
[TBL] [Abstract][Full Text] [Related]
7. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.
Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC
Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224
[TBL] [Abstract][Full Text] [Related]
9. Investigation into the presence of Leishmania antibodies in patients with hepatosplenomegaly.
Kabil SM; Morsy TA; Yousef SM
J Egypt Soc Parasitol; 1988 Jun; 18(1):29-34. PubMed ID: 3373056
[No Abstract] [Full Text] [Related]
10. [Visceral leishmaniasis contracted in Europe (kala-azar)].
Reincke M; Allolio B; Hackenberg E; Cohen S; Winkelmann W; Kaufmann W
Med Klin (Munich); 1990 Apr; 85(4):220-3. PubMed ID: 2191212
[No Abstract] [Full Text] [Related]
11. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.
Peters BS; Fish D; Golden R; Evans DA; Bryceson AD; Pinching AJ
Q J Med; 1990 Nov; 77(283):1101-11. PubMed ID: 2274656
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha (cachectin) in human visceral leishmaniasis.
Morsy TA; el Missiry AG; Sarwat MA; el Rassed MM; Habib FS; Abou Gamra MM
J Egypt Soc Parasitol; 1995 Apr; 25(1):31-51. PubMed ID: 7602171
[TBL] [Abstract][Full Text] [Related]
13. Serological and parasitological examination of some patients with manifestations suggestive leishmaniasis.
Morsy TA; Kabil SM; Yousef SM; el Sadek MM; Lashin AH
J Egypt Soc Parasitol; 1990 Jun; 20(1):35-46. PubMed ID: 2332662
[TBL] [Abstract][Full Text] [Related]
14. Evidence of Leishmania donovani infection in household members residing with visceral leishmaniasis patients.
Saran R; Gupta AK; Sharma MC
J Commun Dis; 1992 Dec; 24(4):242-4. PubMed ID: 1344960
[No Abstract] [Full Text] [Related]
15. Anti-66 kDa antileishmanial antibodies as specific immunodiagnostic probe for visceral leishmaniasis.
Vinayak VK; Mahajan D; Sobti RC; Singla N; Sundar S
Indian J Med Res; 1994 Mar; 99():109-14. PubMed ID: 8063345
[TBL] [Abstract][Full Text] [Related]
16. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis.
Makni S; Ayed K; Ben Said M; Ben Rachid MS
Ann Trop Med Parasitol; 1989 Aug; 83(4):349-55. PubMed ID: 2532497
[TBL] [Abstract][Full Text] [Related]
17. Microscopic agglutination test in detection of Leishmania donovani antibodies.
Majumder R; Sen GP
J Commun Dis; 1992 Dec; 24(4):245-6. PubMed ID: 1344961
[No Abstract] [Full Text] [Related]
18. [Autoantibodies and Leishmania infection].
Julià Benique MR; Salvá F; Hernández M; Matamoros N
Med Clin (Barc); 1991 Jun; 97(5):197-8. PubMed ID: 1921552
[No Abstract] [Full Text] [Related]
19. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
Bhardwaj S; Vasishta RK; Arora SK
Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
[TBL] [Abstract][Full Text] [Related]
20. [Experimental infection with Leishmania in the dog: clinical, pathologic, parasitologic and serologic findings].
Pospischil A; Fiebiger I; Krampitz HE; Weiland G
Zentralbl Veterinarmed B; 1987 Jun; 34(4):288-304. PubMed ID: 3673364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
